Study to Assess Batoclimab in Participants With Active Thyroid Eye Disease

PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

November 23, 2022

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Thyroid Eye Disease
Interventions
DRUG

Batoclimab

Batoclimab is a fully human anti-neonatal fragment crystallizable receptor (FcRn) monoclonal antibody

DRUG

Placebo

Matching Placebo

Trial Locations (93)

19049

Site Number - 6611, Schwerin

19713

Site Number - 1547, Newark

20122

Site Number - 6204, Milan

20149

Site Number - 6203, Milan

21231

Site Number - 1535, Baltimore

24018

Site Number - 1500, Roanoke

27517

Site Number - 1530, Chapel Hill

30281

Site Number - 1554, Stockbridge

33136

Site Number - 1504, Miami

33401

Site Number - 1536, West Palm Beach

33603

Site Number - 1542, Tampa

33952

Site Number - 1538, Port Charlotte

40138

Site Number - 6206, Bologna

43215

Site Number - 1550, Columbus

52242

Site Number - 1545, Iowa City

53705

Site Number - 1509, Madison

55131

Site Number - 6604, Mainz

56100

Site Number - 6200, Pisa

56124

Site Number - 6201, Pisa

60318

Site Number - 6608, Frankfurt am Main

60610

Site Number - 1534, Chicago

72076

Site Number - 6609, Tübingen

75149

Site Number - 1558, Mesquite

75231

Site Number - 1551, Dallas

77030

Site Number - 1508, Houston

80045

Site Number - 1501, Aurora

80131

Site Number - 6205, Napoli

80503

Site Number - 1544, Longmont

89184

Site Number - 1540, Las Vegas

90025

Site Number - 1502, Los Angeles

90033

Site Number - 1505, Los Angeles

90127

Site Number - 6209, Palermo

90210

Site Number - 1557, Beverly Hills

90255

Site Number - 1532, Los Angeles

90505

Site Number - 1531, Torrance

91120

Site Number - 4761, Jerusalem

92011

Site Number - 1539, Carlsbad

92108

Site Number - 1537, San Diego

97232

Site Number - 1507, Portland

1834111

Site Number - 4764, Afula

2210000

Site Number - 4763, Nahariya

4941492

Site Number - 4762, Petah Tikva

5265601

Site Number - 4760, Ramat Gan

02130

Site Number - 1506, Boston

02886

Site Number - 1556, Warwick

T6G 2E1

Site Number - 2502, Edmonton

K1H 8L6

Site Number - 2500, Ottawa

H1T 2M4

Site Number - 2501, Montreal

0101

Site Number - 3452, Tbilisi

0114

Site Number - 3454, Tbilisi

Site Number - 3455, Tbilisi

0159

Site Number - 3450, Tbilisi

Site Number - 3451, Tbilisi

0186

Site Number - 3453, Tbilisi

04103

Site Number - 6610, Leipzig

CAP95125

Site Number - 6207, Catania

00189

Site Number - 6202, Roma

00161

Site Number - 6208, Rome

371-8511

Site Number - 7415, Maebashi

060-8648

Site Number- 7418, Hokkaido

812-0011

Site Number - 7401, Fukuoka

663-8501

Site Number - 7403, Hyōgo

305-8576

Site Number - 7411, Ibaraki

230-8765

Site Number - 7410, Kanagawa

807-8556

Site Number - 7402, Kitakyushu

657-0068

Site Number - 7417, Kobe

860-8556

Site Number - 7416, Kumamoto

889-1692

Site Number - 7414, Miyazaki

852-8501

Site Number - 7407, Nagasaki

467-8602

Site Number - 7406, Nagoya

783-0043

Site Number - 7412, Nankoku

545-0051

Site Number - 7408, Osaka

173-8610

Site Number - 7409, Tokyo

683-8504

Site Number - 7404, Tottori

754-0002

Site Number - 7413, Yamaguchi

44-102

Site Number - 3107, Gliwice

40-514

Site Number - 3103, Katowice

30-688

Site Number - 3101, Krakow

20-171

Site Number - 3104, Lublin

20-562

Site Number - 3102, Lublin

60-354

Site Number - 3105, Lublin

10-561

Site Number - 3106, Olsztyn

02-097

Site Number - 3100, Warsaw

GU2 7XX

Site Number - 7305, Guildford

HU6 7RX

Site Number - 7310, Hull

LE15WW

Site Number - 7309, Leicester

EC1V 2PD

Site Number - 7303, London

SE17EH

Site Number - 7311, London

W1T 6AH

Site Number - 7312, London

W1T 7HA

Site Number - 7313, London

M139WL

Site Number - 7300, Manchester

NE1 3BZ

Site Number - 7302, Newcastle upon Tyne

S102SB

Site Number - 7308, Sheffield

Sponsors
All Listed Sponsors
lead

Immunovant Sciences GmbH

INDUSTRY

NCT05517421 - Study to Assess Batoclimab in Participants With Active Thyroid Eye Disease | Biotech Hunter | Biotech Hunter